Antogen Secures Seed Financing to Advance Next-Generation Immune Surveillance Diagnostics
Antogen, Inc., an emerging life sciences tools and diagnostics company, today announced the closing of its seed financing round. The round was led by iGrow Venture Partners, with participation from a select group of experienced life sciences angel investors.
